The Law of medecaments, with gaps and risks

2017.09.08 Social Victor Ursu Print version

The social impact of medicines is significant, as these products are primarily needed for representatives of socially vulnerable groups, including children, people with disabilities, and older people. Given that the Medicines Law was approved in 1997 and some articles are overcome, a systemic approach is needed to regulate new drug conditions. The proposed bill for public consultations contains a number of specific weaknesses and risks such as the density of pharmacy placement unjustifiably, risks related to the sale of drugs through specialized shops, traceability and flow of medicines are not effective enough, reduced access to compensated medicines in the rural area, the risk of low and counterfeit quality products entering, the regulation of price formation of ineffective medicines and much more.

Maria Cojocaru-Toma, a pharmaceutical policy expert, notes in the analytical note on the Medicines project that the risks and impediments in the bill will ultimately lead to serious deviations from state policies in these areas involving more expensive drugs, of lower quality and inaccessibility, the risk of unwarranted and uncontrolled increase in the consumption of pharmaceuticals.

Maria Lăpteanu, the head of the Ministry of Health, said at the event that the ministry will come up with changes to the drug law and will take into account the needs of the population, especially of the specialized drugstore shops. From an economic point of view, the patient has free access to reach.

The representatives of the pharmacies are of the opinion that there is now a need to channel the efforts for the supply of medicines to the Moldovan population, given that in some regions of the country there are even problems.

The main recommendations for improving the law on medicines aim at adjusting the Draft Law on Medicines to European and international best practices on quality and safety of medicines, ensuring AMDM's monitoring and reporting on the activity of all economic agents involved in the proper assurance of serving the population with medicinal products.

At the same time, the author of the Analytical Note argues that there is a need to improve the text of the Draft Law on Medicines, which contains violations and deviations from unanimously accepted rules on the storage, preservation, quality and release of medicines, including the drafting of terms in the field. There is also a need to conduct a profound and multidimensional analysis of the impact of the Draft Law on Medicines on the Population, including rural areas, in order to ensure the protection of citizens' rights to pharmaceutical care, and changes in the pharmaceutical system to be correlated with the reform of the health system as a whole.

The elaboration of the analytical note was made in the framework of the project on the monitoring of political, social processes and the formulation of political syntheses, implemented by IDIS "Viitorul" in partnership with FriedrichEbert-Stiftung.

For more details, contact the Public Relations Coordinator IDIS Viitorul, Victor URSU at or call 069017396.
Переводчик Google для бизнеса –Инструменты переводчикаПереводчик сайтов

Follow us on

Our social networks

Subscribe on


Connect with us